Skip to main content
Smart Investors Daily
Invesco Nasdaq Biotechnology ETF logo

NASDAQ · IBBQ

Invesco Nasdaq Biotechnology ETF

Financial Services · Asset Management

$34.97

Up+$0.04 (+0.10%)

Updated Sep 25, 2026, 9:32 PM

SID Score

5.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
41.2M
P/E ratio
—
Dividend yield
0.65%
52-week range
$27.46 – $36.84
Volume
44.75K
Avg. volume
20K

Price performance

IBBQ price history

1M range · 20 trading sessions · Daily adjusted prices

IBBQ closed at $34.97 after 20 trading sessions, down 4.06% for the selected period.

Last close
$34.97
Period change
-4.06%
Period low
$34.25
Period high
$36.45
Daily close
View OHLC price history
IBBQ OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 24, 2026$34.52$35.03$34.49$34.9744.75K
Sep 23, 2026$35.50$35.53$34.56$34.7639.88K
Sep 22, 2026$35.05$35.58$34.865$35.4051.95K
Sep 21, 2026$34.59$34.9984$34.485$34.849537.96K
Sep 18, 2026$35.13$35.13$34.6296$34.689325.49K
Sep 17, 2026$34.94$35.21$34.905$35.125822.74K
Sep 16, 2026$34.39$34.62$34.1992$34.355919.69K
Sep 15, 2026$34.47$34.47$34.04$34.2537.89K
Sep 14, 2026$34.52$34.92$34.42$34.8214.09K
Sep 11, 2026$34.93$34.93$34.46$34.47217.43K
Sep 10, 2026$34.91$34.91$34.41$34.4119.85K
Sep 9, 2026$35.20$35.3899$34.92$34.927714.3K
Sep 8, 2026$35.59$35.6199$35.07$35.2023.81K
Sep 4, 2026$36.30$36.30$35.905$36.0512.54K
Sep 3, 2026$36.39$36.52$35.9101$36.2635.22K
Sep 2, 2026$35.93$36.45$35.7472$36.3017.94K
Sep 1, 2026$35.51$35.80$35.48$35.7939.94K
Aug 31, 2026$35.18$35.56$34.86$35.474225.72K
Aug 28, 2026$36.38$36.38$35.39$35.4727.7K
Aug 27, 2026$36.44$36.55$36.285$36.4537.77K

Latest IBBQ news

The latest Smart Investors Daily articles mentioning IBBQ.

IBBQ research

Overview

Company profile and research snapshot.

Company profile

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.